AUDACIA: GENERAL MEETING OF SHAREHOLDERS OF JUNE 15, 2023 – RESULTS OF THE VOTE ON RESOLUTIONS – 06/16/2023 at 6:10 p.m.

• Number of shares making up the share capital: 4,754,054 • Number of shares entitled to vote: 4,716,122 • Total number of votes: 7,906,816 • Number of shares held by shareholders present or represented at the meeting: 3,185,854 • Quorum: 70.8% • Number of votes of shareholders present or represented at the meeting: 6,356,348 Summary…

Read More

ERYTECH announces that the commercial court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma – 2023-06-14 at 20:00

PRESS RELEASE ERYTECH announces that the Commercial Court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma Lyon (France), June 14, 2023 – 8:00 p.m. – ERYTECH Pharma (Euronext Paris and Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drugs in red blood cells, today announces that…

Read More

The Commercial Court rejects Akkadian’s request to postpone the vote on the merger: the shareholders of Pherecydes and Erytech will be able to vote on the merger on June 23, 2023 – 06/14/2023 at 20:00

Nantes, June 14, 2023 – 8 p.m. CEST – Pherecydes Pharma (FR0011651694 – ALPHE), a biotechnology company specializing in precision phage therapy intended to treat resistant and/or complicated bacterial infections, announces today that the Commercial Court of Lyon rejected Akkadian’s request to postpone the vote on the merger with Erytech Pharma (Erytech). Pherecydes Pharma, which…

Read More

ERYTECH announces that the commercial court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma – 2023-06-14 at 20:00

Lyon (France), June 14, 2023 – ERYTECH Pharma (Euronext Paris and Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drugs in red blood cells, today announces that the Commercial Court of Lyon rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma. Erytech welcomes the interim order issued today…

Read More

Impeachment against Trump – Trump will not lose a vote because of the impeachment – News

Contents Author: An analysis by Pascal Weber Trump’s campaign team is closely monitoring which Republicans are responding to Trump’s impeachment. And which do not express themselves. Just over three hours had elapsed last night since Donald Trump made public the impeachment against himself when his campaign sent out another email summarizing all the support expressed…

Read More